Regis Healthcare Future Growth

Future criteria checks 5/6

Regis Healthcare is forecast to grow earnings and revenue by 22.8% and 8.6% per annum respectively. EPS is expected to grow by 22.9% per annum. Return on equity is forecast to be 1901.5% in 3 years.

Key information

22.8%

Earnings growth rate

22.87%

EPS growth rate

Healthcare earnings growth	17.2%
Revenue growth rate	8.6%
Future return on equity	1,901.47%
Analyst coverage	Good
Last updated	08 Jun 2026

Recent future growth updates

Recent updates

Narrative Update • Mar 11

REG: RAD Retention And M&A Pipeline Will Support Future Earnings Upside

Analysts now see a slightly different outlook for Regis Healthcare, with the updated price target moving in line with minor tweaks to revenue growth, profit margin assumptions and future P/E expectations. This results in a refined valuation around A$8.32 per share.

Narrative Update • Feb 25

REG: RAD Retention And Acquisitions Will Support Future Earnings Upside

Analysts have raised their fair value estimate for Regis Healthcare to A$8.32 from A$7.98, reflecting updated assumptions on revenue growth, profit margins, the discount rate and future P/E expectations. What's in the News Regis Healthcare states it will look for acquisition opportunities, supported by what it describes as substantial operating cash flow from its core business and a strong balance sheet with undrawn debt capacity (Key Developments).

Analysis Article • Oct 15

Regis Healthcare Limited (ASX:REG) May Have Run Too Fast Too Soon With Recent 25% Price Plummet

Regis Healthcare Limited ( ASX:REG ) shareholders won't be pleased to see that the share price has had a very rough...

Narrative Update • Sep 23

An Intrinsic Calculation For Regis Healthcare Limited (ASX:REG) Suggests It's 28% Undervalued

Key Insights Regis Healthcare's estimated fair value is AU$10.45 based on 2 Stage Free Cash Flow to Equity Regis...

Analysis Article • Apr 07

Take Care Before Diving Into The Deep End On Regis Healthcare Limited (ASX:REG)

There wouldn't be many who think Regis Healthcare Limited's ( ASX:REG ) price-to-sales (or "P/S") ratio of 1.8x is...

Analysis Article • Dec 20

Investor Optimism Abounds Regis Healthcare Limited (ASX:REG) But Growth Is Lacking

There wouldn't be many who think Regis Healthcare Limited's ( ASX:REG ) price-to-sales (or "P/S") ratio of 1.8x is...

Analysis Article • Sep 12

Regis Healthcare Limited's (ASX:REG) P/S Is Still On The Mark Following 31% Share Price Bounce

The Regis Healthcare Limited ( ASX:REG ) share price has done very well over the last month, posting an excellent gain...

Analysis Article • May 02

Is There An Opportunity With Regis Healthcare Limited's (ASX:REG) 38% Undervaluation?

Key Insights Regis Healthcare's estimated fair value is AU$6.05 based on 2 Stage Free Cash Flow to Equity Regis...

Analysis Article • Mar 21

At AU$3.94, Is It Time To Put Regis Healthcare Limited (ASX:REG) On Your Watch List?

Regis Healthcare Limited ( ASX:REG ), might not be a large cap stock, but it led the ASX gainers with a relatively...

Analysis Article • Feb 28

Regis Healthcare (ASX:REG) Has Announced A Dividend Of A$0.0628

Regis Healthcare Limited's ( ASX:REG ) investors are due to receive a payment of A$0.0628 per share on 11th of April...

Analysis Article • Oct 18

Regis Healthcare Limited's (ASX:REG) CEO Compensation Looks Acceptable To Us And Here's Why

Key Insights Regis Healthcare will host its Annual General Meeting on 23rd of October CEO Linda Mellors' total...

Analysis Article • Aug 29

Regis Healthcare (ASX:REG) Is Paying Out A Larger Dividend Than Last Year

Regis Healthcare Limited ( ASX:REG ) has announced that it will be increasing its dividend from last year's comparable...

Analysis Article • Mar 01

Regis Healthcare (ASX:REG) Is Paying Out Less In Dividends Than Last Year

Regis Healthcare Limited ( ASX:REG ) has announced it will be reducing its dividend payable on the 14th of April to...

Analysis Article • Oct 27

Is Regis Healthcare (ASX:REG) Using Debt Sensibly?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Analysis Article • Aug 26

Regis Healthcare's (ASX:REG) Shareholders Will Receive A Smaller Dividend Than Last Year

Regis Healthcare Limited's ( ASX:REG ) dividend is being reduced from last year's payment covering the same period to...

Analysis Article • Feb 25

Regis Healthcare Limited's (ASX:REG) Intrinsic Value Is Potentially 34% Above Its Share Price

Does the February share price for Regis Healthcare Limited ( ASX:REG ) reflect what it's really worth? Today, we will...

Earnings and Revenue Growth Forecasts

ASX:REG - Analysts future estimates and past financials data (AUD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
6/30/2028	1,608	88	317	382	6
6/30/2027	1,507	73	328	395	6
6/30/2026	1,385	51	272	402	6
12/31/2025	1,265	38	233	389	N/A
9/30/2025	1,213	43	227	348	N/A
6/30/2025	1,161	49	220	306	N/A
3/31/2025	1,130	32	231	308	N/A
12/31/2024	1,098	15	242	309	N/A
9/30/2024	1,056	-3	214	281	N/A
6/30/2024	1,014	-21	187	252	N/A
3/31/2024	947	-18	159	224	N/A
12/31/2023	880	-15	132	195	N/A
9/30/2023	830	-22	93	150	N/A
6/30/2023	781	-28	54	105	N/A
3/31/2023	761	-45	34	78	N/A
12/31/2022	741	-61	14	50	N/A
9/30/2022	733	-50	41	82	N/A
6/30/2022	725	-39	68	115	N/A
3/31/2022	719	-16	N/A	N/A	N/A
12/31/2021	713	8	104	143	N/A
9/30/2021	707	14	96	124	N/A
6/30/2021	701	20	88	105	N/A
3/31/2021	700	8	N/A	N/A	N/A
12/31/2020	699	-4	86	105	N/A
9/30/2020	688	-2	87	116	N/A
6/30/2020	678	-1	88	127	N/A
3/31/2020	655	21	111	156	N/A
12/31/2019	661	39	134	186	N/A
9/30/2019	654	45	N/A	203	N/A
6/30/2019	647	51	N/A	220	N/A
3/31/2019	632	51	N/A	204	N/A
12/31/2018	617	50	N/A	188	N/A
9/30/2018	606	52	N/A	161	N/A
6/30/2018	594	54	N/A	134	N/A
3/31/2018	586	56	N/A	129	N/A
12/31/2017	577	57	N/A	124	N/A
9/30/2017	571	59	N/A	138	N/A
6/30/2017	565	61	N/A	151	N/A
3/31/2017	547	55	N/A	151	N/A
12/31/2016	529	50	N/A	152	N/A
9/30/2016	505	48	N/A	143	N/A
6/30/2016	481	47	N/A	134	N/A
3/31/2016	468	59	N/A	146	N/A
12/31/2015	455	71	N/A	159	N/A
9/30/2015	446	64	N/A	143	N/A
6/30/2015	438	58	N/A	127	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: REG's forecast earnings growth (22.8% per year) is above the savings rate (3.6%).

Earnings vs Market: REG's earnings (22.8% per year) are forecast to grow faster than the Australian market (12.1% per year).

High Growth Earnings: REG's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: REG's revenue (8.6% per year) is forecast to grow faster than the Australian market (6.1% per year).

High Growth Revenue: REG's revenue (8.6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: REG's Return on Equity is forecast to be very high in 3 years time (1901.5%).

Discover growth companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/06/13 19:38
End of Day Share Price	2026/06/12 00:00
Earnings	2025/12/31
Annual Earnings	2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Regis Healthcare Limited is covered by 15 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
William Dunlop	BofA Global Research
David Stanton	CLSA
David Low	Deutsche Bank

Regis Healthcare Future Growth

Future criteria checks 5/6

Key information

Recent future growth updates

Consensus EPS estimates fall by 19%, revenue upgraded

Consensus EPS estimates fall by 10%

Price target decreased by 7.3% to AU$7.98

Price target increased by 7.1% to AU$7.31

Price target increased by 7.5% to AU$4.74

Price target increased by 8.5% to AU$4.37

Recent updates

New minor risk - Insider selling

CEO, MD & Director recently sold AU$1.5m worth of stock

Regis Healthcare Limited to Report Fiscal Year 2026 Results on Aug 28, 2026

Investor sentiment improves as stock rises 17%

REG: RAD Retention And M&A Pipeline Will Support Future Earnings Upside

Consensus EPS estimates fall by 19%, revenue upgraded

First half dividend increased to AU$0.09

REG: RAD Retention And Acquisitions Will Support Future Earnings Upside

Regis Healthcare Limited Announces Ordinary Fully Franked Dividend for the Six Months Ending December 31, 2025, Payable on April 9, 2026

First half 2026 earnings released: EPS: AU$0.045 (vs AU$0.081 in 1H 2025)

Regis Healthcare Limited Announces Appointment of Carmel Monaghan as an Independent Non-Executive Director, Effective 1 February 2026

Regis Healthcare Limited to Report First Half, 2026 Results on Feb 23, 2026

Investor sentiment improves as stock rises 15%

Regis Healthcare Limited (ASX:REG) May Have Run Too Fast Too Soon With Recent 25% Price Plummet

Consensus EPS estimates fall by 10%

Price target decreased by 7.3% to AU$7.98

Australia Aged Care Demand Will Fuel Residential Expansion

New minor risk - Dividend sustainability

Investor sentiment deteriorates as stock falls 22%

Regis Healthcare Limited, Annual General Meeting, Nov 18, 2025

Australia's Aged Care Reforms Will Reshape Service Landscapes

Final dividend of AU$0.081 announced

Full year 2025 earnings: EPS and revenues exceed analyst expectations

Regis Healthcare Limited Announces Franked Ordinary Dividend for the Six Months Ended June 30, 2025, Payable on September 24, 2025

Australia's Aged Care Reforms Will Reshape Service Landscapes

Insider recently sold AU$1.9m worth of stock

When Should You Buy Regis Healthcare Limited (ASX:REG)?

Regis Healthcare Limited (ASX:REG) entered into a binding agreement to acquire Rockpool RACHoldings Pty Ltd for approximately AUD 140 million.

Regis Healthcare Limited to Report Fiscal Year 2025 Results on Aug 25, 2025

An Intrinsic Calculation For Regis Healthcare Limited (ASX:REG) Suggests It's 28% Undervalued

New major risk - Revenue and earnings growth

Take Care Before Diving Into The Deep End On Regis Healthcare Limited (ASX:REG)

First half dividend increased to AU$0.081

First half 2025 earnings: EPS and revenues exceed analyst expectations

Regis Healthcare Limited Resolves to Pay an Interim Dividend for the Half-Year Ended 31 December 2024, Payable on 10 April 2025

Regis Healthcare Limited to Report First Half, 2025 Results on Feb 24, 2025

Price target increased by 7.1% to AU$7.31

Investor Optimism Abounds Regis Healthcare Limited (ASX:REG) But Growth Is Lacking

Regis Healthcare Limited (ASX:REG) acquired Two residential aged care homes in Capel Sound and Mornington from Ti Tree Operations Pty Ltd.

Regis Healthcare Limited Announces Retirement of Bryan Dorman as Non-Executive Director, Effective 26 November 2024

Regis Healthcare Limited, Annual General Meeting, Nov 26, 2024

Regis Healthcare Limited (ASX:REG) agreed to acquire Two residential aged care homes in Capel Sound and Mornington from Ti Tree Operations Pty Ltd for AUD 35.5 million.

Regis Healthcare Limited's (ASX:REG) P/S Is Still On The Mark Following 31% Share Price Bounce

Final dividend of AU$0.066 announced

Price target increased by 7.5% to AU$4.74

Full year 2024 earnings: Revenues exceed analyst expectations

Regis Healthcare Limited to Report Second Half, 2024 Results on Aug 26, 2024

Price target increased by 8.5% to AU$4.37

Non-Executive Director recently sold AU$68m worth of stock

Is There An Opportunity With Regis Healthcare Limited's (ASX:REG) 38% Undervaluation?

At AU$3.94, Is It Time To Put Regis Healthcare Limited (ASX:REG) On Your Watch List?

Upcoming dividend of AU$0.063 per share

Regis Healthcare (ASX:REG) Has Announced A Dividend Of A$0.0628

First half dividend increased to AU$0.063

Price target increased by 7.3% to AU$3.77

Price target increased by 9.0% to AU$3.52

Price target increased by 7.4% to AU$3.43

Regis Healthcare Limited to Report First Half, 2024 Results on Feb 26, 2024

Regis Healthcare Limited Announces Appointment of Jodie Leonard as Independent Non-Executive Director and to Chair the People and Remuneration Committee

Regis Healthcare Limited (ASX:REG) agreed to acquire Cpsm Pty Ltd for AUD 74.2 million.

Price target increased by 11% to AU$3.07

Price target increased by 7.0% to AU$2.77

Consensus EPS estimates upgraded to AU$0.083 loss

Price target increased by 8.7% to AU$2.74

Regis Healthcare Limited's (ASX:REG) CEO Compensation Looks Acceptable To Us And Here's Why

Price target increased by 8.8% to AU$2.59

Upcoming dividend of AU$0.075 per share at 3.8% yield

Regis Healthcare (ASX:REG) Is Paying Out A Larger Dividend Than Last Year

Consensus EPS estimates fall by 14%, revenue upgraded